ID26335A - METHOD FOR PREVENTING RESTENOSIS USING TOKOTRIENOL - Google Patents

METHOD FOR PREVENTING RESTENOSIS USING TOKOTRIENOL

Info

Publication number
ID26335A
ID26335A IDW20001179A ID20001179A ID26335A ID 26335 A ID26335 A ID 26335A ID W20001179 A IDW20001179 A ID W20001179A ID 20001179 A ID20001179 A ID 20001179A ID 26335 A ID26335 A ID 26335A
Authority
ID
Indonesia
Prior art keywords
tokotrienol
preventing restenosis
restenosis
preventing
Prior art date
Application number
IDW20001179A
Other languages
Indonesian (id)
Inventor
Ronald H Lane
F Howard Schneider
Original Assignee
Lipogenic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenic Inc filed Critical Lipogenic Inc
Publication of ID26335A publication Critical patent/ID26335A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
IDW20001179A 1997-11-17 1998-11-17 METHOD FOR PREVENTING RESTENOSIS USING TOKOTRIENOL ID26335A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97170397A 1997-11-17 1997-11-17

Publications (1)

Publication Number Publication Date
ID26335A true ID26335A (en) 2000-12-14

Family

ID=25518699

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001179A ID26335A (en) 1997-11-17 1998-11-17 METHOD FOR PREVENTING RESTENOSIS USING TOKOTRIENOL

Country Status (6)

Country Link
EP (1) EP1037628A4 (en)
JP (1) JP2001522880A (en)
AU (1) AU746369B2 (en)
CA (1) CA2310232A1 (en)
ID (1) ID26335A (en)
WO (1) WO1999025336A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001242811B2 (en) * 2000-03-31 2005-07-14 Eisai R&D Management Co., Ltd. Diuretics containing gamma-tocotrienol
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
DE10115740A1 (en) 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
EP1521603B1 (en) 2002-07-12 2011-01-19 Cook Incorporated Coated medical device
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
WO2005039443A2 (en) 2003-10-21 2005-05-06 Medlogics Device Corporation Gamma-tocopherol therapy for restenosis prevention
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
EP2564843B1 (en) 2005-06-01 2018-12-26 Bioelectron Technology Corporation Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
JP2012502064A (en) 2008-09-10 2012-01-26 エジソン ファーマシューティカルズ， インコーポレイテッド Treatment of pervasive developmental disorders with redox-active therapeutic agents
ES2550634T3 (en) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
MX337990B (en) 2009-08-26 2016-03-30 Edison Pharmaceuticals Inc Methods for the prevention and treatment of cerebral ischemia.
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
RU2613167C2 (en) * 2012-07-19 2017-03-15 Те Огайо Стейт Юниверсити Method of ameliorating clotting pathologies and related materials and methods
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504887A (en) * 1991-11-22 1995-06-01 リポジェニックス，インコーポレイテッド Tocotrienols and tocotrienol-like compounds and methods of using them
DE4333794A1 (en) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Acetylsalicylic acid derivatives for controlling states of inflammation and pain and for the prophylaxis and therapy of thrombosis
EP0669132A1 (en) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis

Also Published As

Publication number Publication date
CA2310232A1 (en) 1999-05-27
EP1037628A1 (en) 2000-09-27
AU746369B2 (en) 2002-04-18
JP2001522880A (en) 2001-11-20
EP1037628A4 (en) 2002-08-21
AU1590299A (en) 1999-06-07
WO1999025336A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
ID26335A (en) METHOD FOR PREVENTING RESTENOSIS USING TOKOTRIENOL
IS8368A (en) New method
FI102426B1 (en) Method for implementing memory
DE69830295D1 (en) control method
FI102424B1 (en) Method for implementing memory
ATE260243T1 (en) N-AROYLPHENYLALANINE DERIVATIVES
ATE235220T1 (en) RESOCINE DERIVATIVES
EE03801B1 (en) Stent
FI971620A (en) authentication method
DE69817186D1 (en) DIAMINORHODAMIN DERIVATIVES
DK0958287T3 (en) Sulfamidmetalloprotease inhibitors
FI102425B1 (en) Method for implementing memory
ID19075A (en) CAPACIC PLACES FOR ASETALDEHIDA
DE69815975D1 (en) control method
DE69841086D1 (en) 5-deoxy-cytidine derivatives
IS5106A (en) New method
DE69816734D1 (en) control method
NO20003079D0 (en) Polymerization-start-up process
DE69829682D1 (en) CIS-DISUBSTITUTED AMINOCYCLOALKYL-PYRROLIDINE DERIVATIVES
NO20003080D0 (en) Polymerization-start-up process
DE69828780D1 (en) AMIDINOCAMPTPTHECIN DERIVATIVES
FI974067A0 (en) Process Foer cellulasbehandling
FI102961B (en) Method for treating ash
ID21138A (en) FILM-THIN TECHNOLOGY FOR HEAD-DRUM
FI970906A (en) The control method